Absorption Midodrine is rapidly absorbed. Absolute bioavailability is 93%, prodrug T max is 30 min, and metabolite T max is 1 to 2 h.
Distribution Neither prodrug nor metabolite is bound to plasma proteins to any significant extent.
Metabolism Major active metabolite is desglymidodrine. Declycination of midodrine to desglymidodrine takes place in many tissues. Both compounds are metabolized in part by the liver.
Elimination Renal Cl of desglymidodrine is 385 mL/min (approximately 80% by active renal secretion). The t ½ is 25 min (midodrine) and 3 to 4 h (desglymidodrine).
Peak Time to peak is 1 h.
Duration Duration is 2 to 3 h.
Special Populations Renal Function Impairment
Use cautiously in patients with urinary retention problems. A lower starting dose (2.5 mg) may be necessary. Assess renal function prior to initial use.
Hepatic Function Impairment
Use with caution, as the liver has a role in the metabolism.
|